These results suggest that AKT-driven KDM5B expression is a key factor for tumorigenicity of PTEN PCa cells, identifying a mechanism by which AKT modifies the epigenome of tumoral cells, increasing the level of H3K4 methylation (Khan et al., 2019). The gene discussed is PTEN; the disease is posterior cortical atrophy.